Coverage and Reimbursement in Genetic Tests
Ethics ResearchEthical, legal and social implications
Genetic Discrimination
Genetic Testing
Health IssuesGenetic testing, personalized medicine
Informed Consent
Intellectual Property and GenomicsGene patenting, guidelines
Online Bioethics Resources
Genome Statute and Legislation DatabaseSearch federal & state law
On October 24, 2012, the National Human Genome Research Institute (NHGRI) and the Center for Medical Technology Policy (CMTP) convened a workshop to explore innovative ways in which genomics-based tests could be covered by public and private payers while generating evidence of the test's impact on medical outcomes, and to develop an action plan enabling future reimbursement of such tests and large-scale sequencing. A summary of that workshop is available now. (Read the summary)
The National Human Genome Research Institute and the National Institute of General Medical Sciences, part of the National Institutes of Health, wrote a policy forum in this week's Science to accompany a research paper on the identifiability of genomic research data. The policy paper reaffirms the Institutes' commitment to the privacy of research participants and the benefits of widespread and open research data sharing. The research paper is from the Whitehead Institute for Biomedical Research in Cambridge, Mass.To view the PDF document(s) on this page, you will need Adobe Reader. ![]()
